Diversified Healthcare Trust Future Growth
Future criteria checks 0/6
Diversified Healthcare Trust is forecast to grow earnings and revenue by 33.4% and 5.5% per annum respectively while EPS is expected to grow by 32.7% per annum.
Key information
33.4%
Earnings growth rate
32.7%
EPS growth rate
Health Care REITs earnings growth | 20.4% |
Revenue growth rate | 5.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Jan 2025 |
Recent future growth updates
Recent updates
Diversified Healthcare Trust: Cash Flow Burn And Debt Refinance Continue To Raise Concerns
Nov 21Diversified Healthcare: The Baby Bonds Still Look The Most Appealing
Nov 05Diversified Healthcare Trust: Progress Being Made, But I'm Still Neutral
Aug 06Diversified Healthcare Trust: A Look At The 9% Yielding Baby Bonds
Mar 05Diversified Healthcare Trust: Hurtin' For Certain
Jan 26Diversified Healthcare Trust declares $0.01 dividend
Oct 13Diversified Healthcare Trust declares $0.01 dividend
Jul 14Diversified Healthcare sells 10% stake in Boston complex for $108M
Jun 29Diversified Healthcare Trust: A Must Avoid REIT
May 16Diversified Healthcare Trust: Fails To Generate Optimism
Mar 09Diversified Healthcare Trust: Starting To Become Appealing
Aug 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,668 | -175 | N/A | N/A | 2 |
12/31/2025 | 1,553 | -227 | N/A | N/A | 2 |
12/31/2024 | 1,486 | -349 | N/A | N/A | 2 |
9/30/2024 | 1,477 | -385 | 87 | 87 | N/A |
6/30/2024 | 1,460 | -352 | 52 | 52 | N/A |
3/31/2024 | 1,435 | -327 | 33 | 33 | N/A |
12/31/2023 | 1,410 | -294 | 10 | 10 | N/A |
9/30/2023 | 1,386 | -256 | 14 | 14 | N/A |
6/30/2023 | 1,352 | -272 | 23 | 23 | N/A |
3/31/2023 | 1,319 | -309 | -27 | -27 | N/A |
12/31/2022 | 1,284 | -16 | -40 | -40 | N/A |
9/30/2022 | 1,283 | 415 | -87 | -87 | N/A |
6/30/2022 | 1,298 | 407 | -122 | -122 | N/A |
3/31/2022 | 1,331 | 482 | -105 | -105 | N/A |
12/31/2021 | 1,383 | 175 | -63 | -63 | N/A |
9/30/2021 | 1,431 | -207 | -14 | -14 | N/A |
6/30/2021 | 1,488 | -225 | 75 | 75 | N/A |
3/31/2021 | 1,552 | -217 | 137 | 137 | N/A |
12/31/2020 | 1,632 | -139 | 159 | 159 | N/A |
9/30/2020 | 1,503 | -175 | 229 | 229 | N/A |
6/30/2020 | 1,365 | -97 | 251 | 251 | N/A |
3/31/2020 | 1,216 | -109 | 281 | 281 | N/A |
12/31/2019 | 1,040 | -88 | 266 | 266 | N/A |
9/30/2019 | 1,069 | -155 | 302 | 302 | N/A |
6/30/2019 | 1,092 | -80 | 340 | 340 | N/A |
3/31/2019 | 1,108 | 81 | 350 | 350 | N/A |
12/31/2018 | 1,117 | 287 | 393 | 393 | N/A |
9/30/2018 | 1,110 | 470 | 371 | 371 | N/A |
6/30/2018 | 1,098 | 459 | N/A | 387 | N/A |
3/31/2018 | 1,086 | 351 | N/A | 389 | N/A |
12/31/2017 | 1,075 | 148 | N/A | 419 | N/A |
9/30/2017 | 1,070 | 125 | N/A | 419 | N/A |
6/30/2017 | 1,068 | 119 | N/A | 422 | N/A |
3/31/2017 | 1,064 | 142 | N/A | 418 | N/A |
12/31/2016 | 1,058 | 141 | N/A | 424 | N/A |
9/30/2016 | 1,051 | 108 | N/A | 427 | N/A |
6/30/2016 | 1,043 | 118 | N/A | 405 | N/A |
3/31/2016 | 1,029 | 116 | N/A | 423 | N/A |
12/31/2015 | 999 | 125 | N/A | 406 | N/A |
9/30/2015 | 961 | 165 | N/A | 390 | N/A |
6/30/2015 | 923 | 164 | N/A | 388 | N/A |
3/31/2015 | 882 | 164 | N/A | 366 | N/A |
12/31/2014 | 845 | 162 | N/A | 351 | N/A |
9/30/2014 | 815 | 193 | N/A | 340 | N/A |
6/30/2014 | 786 | 192 | N/A | 335 | N/A |
3/31/2014 | 766 | 188 | N/A | 323 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DHC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DHC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DHC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DHC's revenue (5.5% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: DHC's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DHC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 22:33 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Diversified Healthcare Trust is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrew Babin | Baird |
Joshua Dennerlein | BofA Global Research |
Bryan Maher | B. Riley Securities, Inc. |